Asian Intensive Care: coming of age
International intensive care conference, Hong Kong, December 14th-15th
Register now!
Click here for details

• pituitary adenomas (GH and TSH secreting tumours which recur following surgery)
• pancreatic islet cell tumours
• metastatic carcinoid tumours
• scintographic imaging of somatostatin receptor positive tumours

• bleeding oesophageal varices
• pancreatic and enteric fistulas
• complications of elective pancreatic surgery
• secretory diarrhoea

• somatostatin receptor positive neuroendocrine tumours
• somatostatin receptor positive adenocarcinomas
• ERCP related pancreatitis
• upper GI bleeding

• dose dependent symptoms of nausea, cramps, fat malabsorption and flatulence
• appear following first administration but disappear after 1-2 weeks of treatment

• reduced glucose tolerance and hyperglycaemia (rarely a problem)
• cholesterol gallstones are more common in patients taking octreotide for > 1 month

©Charles Gomersall, October, 2009 unless otherwise stated. The author, editor and The Chinese University of Hong Kong take no responsibility for any adverse event resulting from the use of this webpage.
Copyright policy    Contributors